ORBIMED ADVISORS LLC – Neurocrine Biosciences, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$95.22M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +5.53% | 47K shares | 12.40M | $106.21 | 896.54K |
| Q2 2022 | share | Decrease | -2.97% | -25.97K shares | 734K | $97.48 | 849.54K |
| Q1 2022 | share | Decrease | -6.05% | -56.4K shares | 2.70M | $93.75 | 875.51K |
| Q4 2021 | share | Decrease | -21.82% | -260.1K shares | -34.95M | $84.63 | 931.91K |
| Q3 2021 | share | Decrease | -3.18% | -39.1K shares | -5.48M | $95.91 | 1.19M |
| Q2 2021 | share | Decrease | -5.42% | -70.6K shares | -6.78M | $97.32 | 1.23M |
| Q1 2021 | share | 0.00% | 0 shares | 1.82M | $97.25 | 1.30M | |
| Q4 2020 | share | 0.00% | 0 shares | -404K | $95.85 | 1.30M | |
| Q3 2020 | share | Increase | +9.76% | 115.8K shares | -19.50M | $96.16 | 1.30M |
| Q2 2020 | share | Increase | +2.68% | 30.9K shares | 44.71M | $122 | 1.18M |
| Q1 2020 | share | Increase | +23.40% | 219.04K shares | -640K | $86.55 | 1.15M |
| Q4 2019 | share | Decrease | -40.58% | -639.2K shares | -41.33M | $107.49 | 935.97K |
| Q3 2019 | share | Decrease | -14.08% | -258.03K shares | -12.83M | $90.11 | 1.57M |
| Q2 2019 | share | 0.00% | 0 shares | -6.72M | $84.43 | 1.83M | |
| Q1 2019 | share | Increase | +270.94% | 1.33M shares | 126.21M | $88.1 | 1.83M |
| Q4 2018 | share | Increase | +258.64% | 356.4K shares | 18.34M | $71.41 | 494.2K |
| Q3 2018 | share | 0.00% | 0 shares | 3.40M | $122.95 | 137.8K | |
| Q2 2018 | share | Increase | +83.73% | 62.8K shares | 7.31M | $98.24 | 137.8K |
| Q1 2018 | share | Increase | 0.00% | 75K shares | 6.22M | $82.93 | 75K |
| Q4 2017 | share | Decrease | -100.00% | -284.84K shares | -17.45M | $77.59 | 0 |
| Q3 2017 | share | 0.00% | 0 shares | 4.35M | $61.28 | 284.84K | |
| Q2 2017 | share | Decrease | -35.46% | -156.5K shares | -6.00M | $46 | 284.84K |
| Q1 2017 | share | Decrease | -79.27% | -1.68M shares | -63.27M | $43.3 | 441.34K |
| Q4 2016 | share | Increase | +17.26% | 313.3K shares | -9.55M | $38.7 | 2.12M |
| Q3 2016 | share | 0.00% | 0 shares | 9.42M | $50.64 | 1.81M | |
| Q2 2016 | share | Decrease | -31.59% | -838.4K shares | -22.44M | $45.45 | 1.81M |
| Q1 2016 | share | Increase | +5.52% | 138.9K shares | -37.31M | $39.55 | 2.65M |